Forecasts

Help
Analyst
Ticker
Result
Analyst Action
AI Recommendation
Period
Limit
Return %
Filters
Performance Current: Return -2.17% • Success Rate 55.0%
Total: 26999 • Pg: 343/1350 ← Back Next →
ULTA Ulta Beauty
2026-03-09 • Telsey Advisory
Δh% 2.87%
Target Raised Buy
Price Then 642.22
Price h 660.66
Target 715
DOW Dow Inc.
2026-03-09 • Fermium Research
Δh% -3.7%
Rating Upgraded Buy
Price Then 34.31
Price h 33.04
Target 38
A Agilent Technologies
2026-03-09 • Fermium Research
Δh% 52.32%
Update Buy
Price Then 114.21
Price h 173.96
Target 150
EPR EPR Properties
2026-03-09 • UBS
Δh% 4.07%
Target Raised Buy
Price Then 57.8
Price h 60.15
Target 58
MO Altria
2026-03-09 • UBS
Δh% 17.3%
Target Raised Buy
Price Then 67.04
Price h 78.64
Target 74
XENE Xenon Pharmaceuticals
2026-03-09 • Stifel Nicolaus
Δh% -34.26%
Target Raised Sell
Price Then 61.58
Price h 40.48
Target 89
LYV Live Nation
2026-03-09 • Guggenheim
Δh% 7.94%
Update Hold
Price Then 165.33
Price h 178.45
Target 180
LYB LyondellBasell
2026-03-09 • Fermium Research
Δh% -3.58%
Rating Upgraded Hold
Price Then 66.82
Price h 64.43
Target 74
HIMS Hims & Hers Health
2026-03-09 • Needham
Δh% -11.72%
Update Sell
Price Then 22.3501
Price h 19.73
Target 30
PFE Pfizer
2026-03-09 • BMO Capital
Δh% 9.08%
Update Buy
Price Then 26.485
Price h 28.89
Target 30
XENE Xenon Pharmaceuticals
2026-03-09 • Robert W. Baird
Δh% -35.5%
Target Raised Sell
Price Then 62.76
Price h 40.48
Target 97
XENE Xenon Pharmaceuticals
2026-03-09 • Morgan Stanley
Δh% -35.5%
Target Raised Sell
Price Then 62.76
Price h 40.48
Target 97
DNTH Dianthus Therapeutics
2026-03-09 • Robert W. Baird
Δh% 15.88%
Target Raised Hold
Price Then 79.23
Price h 91.81
Target 132
QURE UniQure
2026-03-09 • Chardan Capital
Δh% 32.35%
Target Raised Sell
Price Then 17.99
Price h 23.81
Target 31
CAH Cardinal Health
2026-03-09 • Leerink Partners
Δh% 26.46%
Update Buy
Price Then 222.28
Price h 281.1
Target 275
XENE Xenon Pharmaceuticals
2026-03-09 • Guggenheim
Δh% -35.5%
Target Raised Sell
Price Then 62.76
Price h 40.48
Target 90
KEX Kirby Corporation
2026-03-09 • Evercore ISI
Δh% 3.11%
Update Hold
Price Then 125.81
Price h 129.72
Target 138
DNTH Dianthus Therapeutics
2026-03-09 • Jefferies
Δh% 15.88%
Target Raised Hold
Price Then 79.23
Price h 91.81
Target 98
XENE Xenon Pharmaceuticals
2026-03-09 • Jefferies
Δh% -35.5%
Target Raised Sell
Price Then 62.76
Price h 40.48
Target 100
XENE Xenon Pharmaceuticals
2026-03-09 • RBC Capital
Δh% -35.5%
Target Raised Sell
Price Then 62.76
Price h 40.48
Target 80
Date ↑ Analyst Stock Action AI at Time Price Then Price h Δh% Target Portfolio
2026-03-09 Telsey Advisory
ULTA Ulta Beauty
Target Raised Buy 642.22 660.66 2.87% 715
2026-03-09 Fermium Research
DOW Dow Inc.
Rating Upgraded Buy 34.31 33.04 -3.7% 38
2026-03-09 Fermium Research
A Agilent Technologies
Update Buy 114.21 173.96 52.32% 150
2026-03-09 UBS
EPR EPR Properties
Target Raised Buy 57.8 60.15 4.07% 58
2026-03-09 UBS
MO Altria
Target Raised Buy 67.04 78.64 17.3% 74
2026-03-09 Stifel Nicolaus
XENE Xenon Pharmaceuticals
Target Raised Sell 61.58 40.48 -34.26% 89
2026-03-09 Guggenheim
LYV Live Nation
Update Hold 165.33 178.45 7.94% 180
2026-03-09 Fermium Research
LYB LyondellBasell
Rating Upgraded Hold 66.82 64.43 -3.58% 74
2026-03-09 Needham
HIMS Hims & Hers Health
Update Sell 22.3501 19.73 -11.72% 30
2026-03-09 BMO Capital
PFE Pfizer
Update Buy 26.485 28.89 9.08% 30
2026-03-09 Robert W. Baird
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 40.48 -35.5% 97
2026-03-09 Morgan Stanley
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 40.48 -35.5% 97
2026-03-09 Robert W. Baird
DNTH Dianthus Therapeutics
Target Raised Hold 79.23 91.81 15.88% 132
2026-03-09 Chardan Capital
QURE UniQure
Target Raised Sell 17.99 23.81 32.35% 31
2026-03-09 Leerink Partners
CAH Cardinal Health
Update Buy 222.28 281.1 26.46% 275
2026-03-09 Guggenheim
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 40.48 -35.5% 90
2026-03-09 Evercore ISI
KEX Kirby Corporation
Update Hold 125.81 129.72 3.11% 138
2026-03-09 Jefferies
DNTH Dianthus Therapeutics
Target Raised Hold 79.23 91.81 15.88% 98
2026-03-09 Jefferies
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 40.48 -35.5% 100
2026-03-09 RBC Capital
XENE Xenon Pharmaceuticals
Target Raised Sell 62.76 40.48 -35.5% 80